Rekdal, Ö., Yamazaki, T., Sveinbjornsson, B., Saunders, A., & Zitvogel, L. (2015). Anticancer effect obtained against MCA205 sarcoma following treatment with the oncolytic peptide LTX-315 in combination with immune checkpoint inhibitors. J Immunother Cancer.
Chicago ZitierstilRekdal, Öystein, Takahiro Yamazaki, Baldur Sveinbjornsson, Andrew Saunders, und Laurence Zitvogel. "Anticancer Effect Obtained against MCA205 Sarcoma Following Treatment With the Oncolytic Peptide LTX-315 in Combination With Immune Checkpoint Inhibitors." J Immunother Cancer 2015.
MLA ZitierstilRekdal, Öystein, et al. "Anticancer Effect Obtained against MCA205 Sarcoma Following Treatment With the Oncolytic Peptide LTX-315 in Combination With Immune Checkpoint Inhibitors." J Immunother Cancer 2015.